Loading…

Redshifted biexciton and trion lines in strongly confined (211)B InAs/GaAs piezoelectric quantum dots

The emission lines of strongly confined (211)B InAs/GaAs quantum dots (QDs), embedded in short-period GaAs/AlAs superlattices, are thoroughly characterized by a range of single-dot spectroscopy techniques, including cross correlation photon-counting measurements. Contrary to what is expected for a p...

Full description

Saved in:
Bibliographic Details
Published in:Journal of applied physics 2022-03, Vol.131 (12)
Main Authors: Chatzarakis, N. G., Amargianitakis, E. A., Germanis, S., Stavrinidis, A., Konstantinidis, G., Hatzopoulos, Z., Pelekanos, N. T.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The emission lines of strongly confined (211)B InAs/GaAs quantum dots (QDs), embedded in short-period GaAs/AlAs superlattices, are thoroughly characterized by a range of single-dot spectroscopy techniques, including cross correlation photon-counting measurements. Contrary to what is expected for a piezoelectric QD system, the single-dot biexciton line is found redshifted with respect to the exciton one by as many as 6 meV. This comes in striking contrast to previous reports on the same QD system, without additional confinement, where the biexciton lines always showed up at higher energies than the exciton, by 4–13 meV. In addition, two charged exciton lines are identified for the first time in a piezoelectric InAs-based QD. A positively charged (Χ+) and a negatively charged (Χ−) trion line are observed 1.5 and 7.5 meV below the neutral exciton line, respectively. Our results pave the way to an enhanced understanding of the excitonic transitions in (211)B QDs and highlight the possible role of strong confinement and accompanying correlation effects as a means to tailor the transition energies of multi-particle states in semiconductor QDs.
ISSN:0021-8979
1089-7550
DOI:10.1063/5.0084931